Skip to content
ClinCalc Pro
Menu
Topical Antibiotic-Steroid — Otitis Externa

Framycetin / Sofradex

Brand names: Sofradex (framycetin + dexamethasone + gramicidin)

Framycetin sulfate is an aminoglycoside antibiotic used topically in the ear, including in the compound preparation Sofradex which also contains the corticosteroid dexamethasone and the antibiotic gramicidin, for otitis externa.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Framycetin and gramicidin act as topical antibacterial agents against common ear pathogens, while the dexamethasone component in Sofradex reduces local inflammation and oedema.

Prescribing in practice

  • Avoid use when the tympanic membrane is perforated, as the aminoglycoside framycetin can cause ototoxicity if it reaches the middle ear.
  • Aminoglycosides such as framycetin can cause local hypersensitivity and contact sensitisation, so discontinue if local reactions develop.
  • Limit to short courses and review if symptoms persist to reduce sensitisation and the risk of fungal or resistant superinfection.

Monitoring

Monitor clinically for resolution and for any new hearing disturbance, tinnitus or local hypersensitivity during use.

Counselling the patient

  • Use only in the affected ear and for the short course advised.
  • Stop and seek advice if you notice dizziness, hearing changes, ringing in the ears or a rash.
  • Let the clinician know if your eardrum may be perforated.

Evidence & guidelines

Topical antibiotic-corticosteroid ear preparations are an established treatment for otitis externa, used cautiously in the presence of a perforated eardrum per UK ENT guidance.

Reference: ENT-UK Otitis Externa Guidelines; NICE CKS Otitis Externa; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.